NFKB1 and acute myeloid leukemia: This is further supported by the fact that both mitochondrial function, adipocytes, and the central metabolic pathway Peroxisome proliferator-activated receptor α (PPARA) appear to be affected by NF-κB inhibition in AML based on the GO-mapping.